Skip to main content

CORRECTION article

Front. Oncol., 30 August 2022
Sec. Breast Cancer
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1016189
This article is part of the Research Topic Advancements in Metastatic Breast Cancer: Predictive and Prognostic Biomarkers, and Molecular Mechanisms View all 17 articles

Corrigendum: The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization

This article is a correction to:

  1. The NFAT3/RERG Complex in Luminal Breast Cancers Is Required to Inhibit Cell Invasion and May Be Correlated With an Absence of Axillary Lymph Nodes Colonization

    1. Read original article
Lucie CoillardLucie Coillard1Frdric GuaddachiFrédéric Guaddachi1Maëlle RaluMaëlle Ralu1Eva BrabencovaEva Brabencova2Christian GarbarChristian Garbar2Armand BensussanArmand Bensussan1Morgane Le BrasMorgane Le Bras1Jacqueline Lehmann-Che,Jacqueline Lehmann-Che1,3Sbastien Jauliac*Sébastien Jauliac1*
  • 1Université de Paris, Research Saint Louis Institute (IRSL), Institut National de la Santé et de la Recherche Médicale, Human Immunology Pathophysiology Immunotherapy (INSERM HIPI) U976, Paris, France
  • 2Department of Biopathology, Centre Régional de Lutte Contre le Cancer, Institut Godinot, Reims, France
  • 3Molecular Oncology Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint Louis, Paris, France

A Corrigendum on
The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization

by Coillard L, Guaddachi F, Ralu M, Brabencova E, Garbar C, Bensussan A, Le Bras M, Lehmann-Che J and Jauliac S (2022). Front. Oncol. 12:804868. doi: 10.3389/fonc.2022.804868

In the published article, there was an error in the abstract. NFAT3/REG should be replaced by NFAT3/RERG.

A correction has been made to Abstract. The corrected sentence appears below:

“We have shown an increase of the quantity of the NFAT3/RERG complexes in patients without axillary lymph node colonization and therefore proposed that the detection of this complex may be a non-invasive marker of axillary lymph node colonization.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: breast cancer, NFAT3/c4, RERG, invasion, lymph nodes metastasis

Citation: Coillard L, Guaddachi F, Ralu M, Brabencova E, Garbar C, Bensussan A, Le Bras M, Lehmann-Che J and Jauliac S (2022) Corrigendum: The NFAT3/RERG complex in luminal breast cancers is required to inhibit cell invasion and may be correlated with an absence of axillary lymph nodes colonization. Front. Oncol. 12:1016189. doi: 10.3389/fonc.2022.1016189

Received: 11 August 2022; Accepted: 12 August 2022;
Published: 30 August 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Coillard, Guaddachi, Ralu, Brabencova, Garbar, Bensussan, Le Bras, Lehmann-Che and Jauliac. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sébastien Jauliac, sebastien.jauliac@inserm.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.